226 related articles for article (PubMed ID: 29880828)
1. Angiogenic Factors produced by Hypoxic Cells are a leading driver of Anastomoses in Sprouting Angiogenesis-a computational study.
Moreira-Soares M; Coimbra R; Rebelo L; Carvalho J; D M Travasso R
Sci Rep; 2018 Jun; 8(1):8726. PubMed ID: 29880828
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
You JJ; Yang CH; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
[TBL] [Abstract][Full Text] [Related]
3. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
8. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
9. Simulation of tumor induced angiogenesis using an analytical adaptive modeling including dynamic sprouting and blood flow modeling.
Naghavi N; Hosseini FS; Sardarabadi M; Kalani H
Microvasc Res; 2016 Sep; 107():51-64. PubMed ID: 27179697
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
11. Apln-CreERT:mT/mG reporter mice as a tool for sprouting angiogenesis study.
Pi J; Cheng Y; Sun H; Chen X; Zhuang T; Liu J; Li Y; Chang H; Zhang L; Zhang Y; Tao T
BMC Ophthalmol; 2017 Sep; 17(1):163. PubMed ID: 28865439
[TBL] [Abstract][Full Text] [Related]
12. A cellular Potts model analyzing differentiated cell behavior during in vivo vascularization of a hypoxic tissue.
Scianna M; Bassino E; Munaron L
Comput Biol Med; 2015 Aug; 63():143-56. PubMed ID: 26079199
[TBL] [Abstract][Full Text] [Related]
13. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
Hall AP
Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
[No Abstract] [Full Text] [Related]
14. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
15. IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis.
Yang T; Lin Q; Zhao M; Hu Y; Yu Y; Jin J; Zhou H; Hu X; Wei R; Zhang X; Yang X; Liu G; Lu P; Xu G; Yang J; Corry DB; Su SB; Liu S; Liu X
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2638-46. PubMed ID: 26515414
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
17. Computational modelling suggests complex interactions between interstitial flow and tumour angiogenesis.
Vilanova G; Burés M; Colominas I; Gomez H
J R Soc Interface; 2018 Sep; 15(146):. PubMed ID: 30185542
[TBL] [Abstract][Full Text] [Related]
18. Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy.
Loukovaara S; Gucciardo E; Repo P; Vihinen H; Lohi J; Jokitalo E; Salven P; Lehti K
Acta Ophthalmol; 2015 Sep; 93(6):512-23. PubMed ID: 25899460
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
[TBL] [Abstract][Full Text] [Related]
20. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
